Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.
Duchenne muscular dystrophy (DMD) is an X-linked muscle disease caused by mutations in the dystrophin gene. The pathology of DMD manifests in patients with progressive muscle weakness, loss of ambulation and ultimately death. One of the characteristics of DMD is muscle inflammation, and dystrophin-d...
Main Authors: | Margaret E Benny Klimek, Arpana Sali, Sree Rayavarapu, Jack H Van der Meulen, Kanneboyina Nagaraju |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4877010?pdf=render |
Similar Items
-
The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice.
by: Arpana Sali, et al.
Published: (2013-01-01) -
IL-6 signaling blockade increases inflammation but does not affect muscle function in the <it>mdx</it> mouse
by: Kostek Matthew C, et al.
Published: (2012-06-01) -
Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype.
by: Sree Rayavarapu, et al.
Published: (2010-09-01) -
Glucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouse.
by: Arpana Sali, et al.
Published: (2012-01-01) -
Daily supplementation of D-ribose shows no therapeutic benefits in the MHC-I transgenic mouse model of inflammatory myositis.
by: William Coley, et al.
Published: (2013-01-01)